Valeo Pharmainc (VPH.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.660 unch (unch) 03/28/22 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.660 unch (unch) -
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2023 | 10-2022 | 10-2021 | 10-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,502 | 22,501 | 2,043 | 2,836 | 335 |
| Receivables | 6,565 | 5,428 | 1,798 | 1,220 | 613 |
| Inventories | 10,246 | 9,980 | 7,675 | 881 | 561 |
| TOTAL | $25,243 | $40,529 | $12,350 | $5,410 | $1,651 |
| Non-Current Assets | |||||
| PPE Net | 2,664 | 2,254 | 2,141 | 605 | 296 |
| Intangibles | 13,300 | 15,482 | 6,539 | 4,948 | 3,860 |
| TOTAL | $15,964 | $17,736 | $8,680 | $5,553 | $4,156 |
| Total Assets | $41,207 | $58,265 | $21,030 | $10,963 | $5,807 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,601 | 743 | 4,854 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,992 | 3,737 | 7,320 | 3,381 | 4,377 |
| Accrued Expenses | 2,277 | 1,394 | 266 | 103 | N/A |
| Other current liabilities | N/A | 308 | N/A | N/A | N/A |
| TOTAL | $20,274 | $15,339 | $15,334 | $4,278 | $4,477 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,164 | 59,533 | 1,605 | 2,967 | 1,001 |
| aiOther Non-Current Liabilities | 771 | 127 | 873 | 416 | 351 |
| TOTAL | $61,270 | $60,774 | $3,643 | $3,616 | $1,352 |
| Total Liabilities | $81,544 | $76,113 | $18,977 | $7,894 | $5,829 |
| Shareholders' Equity | |||||
| Common Shares | 31,696 | 26,359 | 24,616 | 15,024 | 8,829 |
| Retained earnings | -82,264 | -54,456 | -28,710 | -14,477 | -9,716 |
| Other shareholders' equity | 5,649 | 5,839 | 3,450 | 911 | 273 |
| TOTAL | $-40,337 | $-17,848 | $2,053 | $3,069 | $-22 |
| Total Liabilities And Equity | $41,207 | $58,265 | $21,030 | $10,963 | $5,807 |